These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 32208845

  • 1. Dabigatran Reversal Before Intravenous Tenecteplase in Acute Ischemic Stroke.
    Beharry J, Waters MJ, Drew R, Fink JN, Wilson D, Campbell BCV, Parsons MW, Kleinig TJ, Wu TY.
    Stroke; 2020 May; 51(5):1616-1619. PubMed ID: 32208845
    [Abstract] [Full Text] [Related]

  • 2. Symptomatic Intracranial Hemorrhage With Tenecteplase vs Alteplase in Patients With Acute Ischemic Stroke: The Comparative Effectiveness of Routine Tenecteplase vs Alteplase in Acute Ischemic Stroke (CERTAIN) Collaboration.
    Warach SJ, Ranta A, Kim J, Song SS, Wallace A, Beharry J, Gibson D, Cadilhac DA, Bladin CF, Kleinig TJ, Harvey J, Palanikumar L, Doss VT, Marescalco R, Fink JN, Tyson A, Schlick KH, Noh L, Wilson D, Figueroa S, Pech MA, Paletz LB, Lewis MK, Castro M, Sahlein DH, Lafranchise EF, Sandall J, Asif KS, Geraghty SR, Cullis PA, Malisch T, Neill TA, LaMonte MP, Campbell BCV, Wu TY.
    JAMA Neurol; 2023 Jul 01; 80(7):732-738. PubMed ID: 37252708
    [Abstract] [Full Text] [Related]

  • 3. Routine Use of Tenecteplase for Thrombolysis in Acute Ischemic Stroke.
    Zhong CS, Beharry J, Salazar D, Smith K, Withington S, Campbell BCV, Wilson D, Le Heron C, Mason D, Duncan R, Reimers J, Mein-Smith F, Diprose WK, Barber PA, Ranta A, Fink JN, Wu TY.
    Stroke; 2021 Mar 01; 52(3):1087-1090. PubMed ID: 33588597
    [Abstract] [Full Text] [Related]

  • 4. Intravenous Thrombolysis After Idarucizumab Application in Acute Stroke Patients-A Potentially Increased Sensitivity of Thrombi to Lysis?
    Pretnar Oblak J, Sabovic M, Frol S.
    J Stroke Cerebrovasc Dis; 2019 Mar 01; 28(3):768-773. PubMed ID: 30527792
    [Abstract] [Full Text] [Related]

  • 5. Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report.
    Agosti S, Casalino L, Rocci E, Zaccone G, Rota E.
    J Med Case Rep; 2017 Aug 15; 11(1):224. PubMed ID: 28806993
    [Abstract] [Full Text] [Related]

  • 6. Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen Activator.
    Bissig D, Manjunath R, Traylor BR, Richman DP, Ng KL.
    J Stroke Cerebrovasc Dis; 2017 Jun 15; 26(6):e102-e104. PubMed ID: 28416406
    [Abstract] [Full Text] [Related]

  • 7. Intravenous tPA (Tissue-Type Plasminogen Activator) in Patients With Acute Ischemic Stroke Taking Non-Vitamin K Antagonist Oral Anticoagulants Preceding Stroke.
    Jin C, Huang RJ, Peterson ED, Laskowitz DT, Hernandez AF, Federspiel JJ, Schwamm LH, Bhatt DL, Smith EE, Fonarow GC, Xian Y.
    Stroke; 2018 Sep 15; 49(9):2237-2240. PubMed ID: 30354981
    [Abstract] [Full Text] [Related]

  • 8. Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke.
    Campbell BCV, Mitchell PJ, Churilov L, Yassi N, Kleinig TJ, Dowling RJ, Yan B, Bush SJ, Dewey HM, Thijs V, Scroop R, Simpson M, Brooks M, Asadi H, Wu TY, Shah DG, Wijeratne T, Ang T, Miteff F, Levi CR, Rodrigues E, Zhao H, Salvaris P, Garcia-Esperon C, Bailey P, Rice H, de Villiers L, Brown H, Redmond K, Leggett D, Fink JN, Collecutt W, Wong AA, Muller C, Coulthard A, Mitchell K, Clouston J, Mahady K, Field D, Ma H, Phan TG, Chong W, Chandra RV, Slater LA, Krause M, Harrington TJ, Faulder KC, Steinfort BS, Bladin CF, Sharma G, Desmond PM, Parsons MW, Donnan GA, Davis SM, EXTEND-IA TNK Investigators.
    N Engl J Med; 2018 Apr 26; 378(17):1573-1582. PubMed ID: 29694815
    [Abstract] [Full Text] [Related]

  • 9. Idarucizumab for Intravenous Thrombolysis and Endovascular Thrombectomy in Acute Stroke: A Case Report.
    Lin YT, Lai YJ, Lai TH.
    J Emerg Med; 2020 Mar 26; 58(3):e113-e116. PubMed ID: 31744711
    [Abstract] [Full Text] [Related]

  • 10. Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic Stroke: The EXTEND-IA TNK Part 2 Randomized Clinical Trial.
    Campbell BCV, Mitchell PJ, Churilov L, Yassi N, Kleinig TJ, Dowling RJ, Yan B, Bush SJ, Thijs V, Scroop R, Simpson M, Brooks M, Asadi H, Wu TY, Shah DG, Wijeratne T, Zhao H, Alemseged F, Ng F, Bailey P, Rice H, de Villiers L, Dewey HM, Choi PMC, Brown H, Redmond K, Leggett D, Fink JN, Collecutt W, Kraemer T, Krause M, Cordato D, Field D, Ma H, O'Brien B, Clissold B, Miteff F, Clissold A, Cloud GC, Bolitho LE, Bonavia L, Bhattacharya A, Wright A, Mamun A, O'Rourke F, Worthington J, Wong AA, Levi CR, Bladin CF, Sharma G, Desmond PM, Parsons MW, Donnan GA, Davis SM, EXTEND-IA TNK Part 2 investigators.
    JAMA; 2020 Apr 07; 323(13):1257-1265. PubMed ID: 32078683
    [Abstract] [Full Text] [Related]

  • 11. Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan.
    Fang CW, Tsai YT, Chou PC, Chen HM, Lu CM, Tsao CR, Chen CL, Sun MC, Shih YS, Hsieh CY, Chen LA, Chen PL, Yeh JT, Li YH.
    J Stroke Cerebrovasc Dis; 2019 Mar 07; 28(3):815-820. PubMed ID: 30573284
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany - A national case collection.
    Kermer P, Eschenfelder CC, Diener HC, Grond M, Abdalla Y, Althaus K, Berrouschot J, Cangür H, Daffertshofer M, Edelbusch S, Gröschel K, Haase CG, Harloff A, Held V, Kauert A, Kraft P, Lenz A, Müllges W, Obermann M, Partowi S, Purrucker J, Ringleb PA, Röther J, Rossi R, Schäfer N, Schneider A, Schuppner R, Seitz RJ, Szabo K, Wruck R.
    Int J Stroke; 2017 Jun 07; 12(4):383-391. PubMed ID: 28494694
    [Abstract] [Full Text] [Related]

  • 14. Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany-Updated series of 120 cases.
    Kermer P, Eschenfelder CC, Diener HC, Grond M, Abdalla Y, Abraham A, Althaus K, Becks G, Berrouschot J, Berthel J, Bode FJ, Burghaus L, Cangür H, Daffertshofer M, Edelbusch S, Eggers J, Gerlach R, Gröschel K, Große-Dresselhaus F, Günther A, Haase CG, Haensch CA, Harloff A, Heckmann JG, Held V, Hieber M, Kauert A, Kern R, Kerz T, Köhrmann M, Kraft P, Kühnlein P, Latta J, Leinisch E, Lenz A, Leithner C, Neumann-Haefelin T, Mäurer M, Müllges W, Nolte CH, Obermann M, Partowi S, Patzschke P, Poli S, Pulkowski U, Purrucker J, Rehfeldt T, Ringleb PA, Röther J, Rossi R, El-Sabassy H, Sauer O, Schackert G, Schäfer N, Schellinger PD, Schneider A, Schuppner R, Schwab S, Schwarte O, Seitz RJ, Senger S, Shah YP, Sindern E, Sparenberg P, Steiner T, Szabo K, Urbanek C, Sarnowksi BV, Weissenborn K, Wienecke P, Witt K, Wruck R, Wunderlich S.
    Int J Stroke; 2020 Aug 07; 15(6):609-618. PubMed ID: 31955706
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Acute reversal of dabigatran with Idarucizumab for intravenous thrombolysis as acute stroke treatment.
    Meyer D, Chu F, Derry K, Hailey L.
    J Clin Neurosci; 2019 Jan 07; 59():355-357. PubMed ID: 30309801
    [Abstract] [Full Text] [Related]

  • 17. Switching to Tenecteplase for Stroke Thrombolysis: Real-World Experience and Outcomes in a Regional Stroke Network.
    Mahawish K, Gommans J, Kleinig T, Lallu B, Tyson A, Ranta A.
    Stroke; 2021 Oct 07; 52(10):e590-e593. PubMed ID: 34465202
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Idarucizumab-facilitated intravenous thrombolysis in acute stroke with dabigatran: Two cases with hemorrhagic transformation.
    Tsai YT, Hsiao YJ, Tsai LK, Yen PS, Lin FY, Lu CH, Fang CW.
    J Neurol Sci; 2018 May 15; 388():155-157. PubMed ID: 29627012
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.